NanoViricides (NNVC) Competitors $1.40 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNVC vs. ORMP, CHRS, IOBT, SRZN, MGNX, CLYM, CLLS, TCRX, OKYO, and UNCYShould you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include Oramed Pharmaceuticals (ORMP), Coherus Oncology (CHRS), IO Biotech (IOBT), Surrozen (SRZN), MacroGenics (MGNX), Climb Bio (CLYM), Cellectis (CLLS), TScan Therapeutics (TCRX), OKYO Pharma (OKYO), and Unicycive Therapeutics (UNCY). These companies are all part of the "pharmaceutical products" industry. NanoViricides vs. Its Competitors Oramed Pharmaceuticals Coherus Oncology IO Biotech Surrozen MacroGenics Climb Bio Cellectis TScan Therapeutics OKYO Pharma Unicycive Therapeutics Oramed Pharmaceuticals (NASDAQ:ORMP) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Do analysts rate ORMP or NNVC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oramed Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00NanoViricides 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation and earnings, ORMP or NNVC? NanoViricides has lower revenue, but higher earnings than Oramed Pharmaceuticals. Oramed Pharmaceuticals is trading at a lower price-to-earnings ratio than NanoViricides, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOramed Pharmaceuticals$1.34M68.59-$19.06M-$0.44-5.11NanoViricidesN/AN/A-$8.29M-$0.70-2.00 Does the media prefer ORMP or NNVC? In the previous week, Oramed Pharmaceuticals had 4 more articles in the media than NanoViricides. MarketBeat recorded 4 mentions for Oramed Pharmaceuticals and 0 mentions for NanoViricides. Oramed Pharmaceuticals' average media sentiment score of 0.46 beat NanoViricides' score of 0.00 indicating that Oramed Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Oramed Pharmaceuticals Neutral NanoViricides Neutral Is ORMP or NNVC more profitable? Oramed Pharmaceuticals' return on equity of -11.34% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets Oramed PharmaceuticalsN/A -11.34% -10.73% NanoViricides N/A -87.90%-78.69% Which has more risk & volatility, ORMP or NNVC? Oramed Pharmaceuticals has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. Comparatively, NanoViricides has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Do insiders and institutionals hold more shares of ORMP or NNVC? 12.7% of Oramed Pharmaceuticals shares are owned by institutional investors. Comparatively, 10.3% of NanoViricides shares are owned by institutional investors. 13.7% of Oramed Pharmaceuticals shares are owned by insiders. Comparatively, 4.6% of NanoViricides shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryOramed Pharmaceuticals beats NanoViricides on 10 of the 12 factors compared between the two stocks. Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNVC vs. The Competition Export to ExcelMetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$22.50M$753.31M$5.45B$20.29BDividend YieldN/A4.84%5.36%3.76%P/E Ratio-1.941.0626.3927.49Price / SalesN/A219.70406.6638.27Price / CashN/A23.4425.8817.85Price / Book2.125.937.924.54Net Income-$8.29M-$27.56M$3.15B$985.09M7 Day Performance2.19%-1.06%2.20%1.70%1 Month Performance-7.89%5.92%4.39%4.05%1 Year Performance-18.60%11.18%32.26%12.20% NanoViricides Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNVCNanoViricides0.4129 of 5 stars$1.40flatN/A-18.6%$22.50MN/A-1.9420ORMPOramed Pharmaceuticals0.5875 of 5 stars$2.11-0.9%N/A-16.3%$87.01M$1.34M-4.8010Gap UpCHRSCoherus Oncology4.1489 of 5 stars$0.73-2.7%$4.68+544.5%-57.0%$86.62M$266.96M-0.64330Positive NewsIOBTIO Biotech3.2047 of 5 stars$1.30flat$9.33+617.9%+23.1%$85.64MN/A0.0030Positive NewsSRZNSurrozen3.1688 of 5 stars$9.02-9.7%$38.50+326.8%-17.6%$85.54M$10.65M0.0080Positive NewsMGNXMacroGenics4.0802 of 5 stars$1.32+0.8%$5.71+332.9%-72.0%$82.65M$149.96M-1.48430News CoverageAnalyst DowngradeCLYMClimb Bio3.5461 of 5 stars$1.20-0.8%$9.00+650.0%N/A$81.77MN/A0.009CLLSCellectis2.9787 of 5 stars$1.44-2.0%$4.00+177.8%-22.5%$81.71M$49.22M-1.67290Gap DownTCRXTScan Therapeutics2.8832 of 5 stars$1.45+0.7%$7.80+437.9%-76.1%$81.49M$2.82M0.00100Gap UpOKYOOKYO Pharma2.5999 of 5 stars$2.19-7.6%$7.00+219.6%+105.9%$80.19MN/A0.007Gap DownUNCYUnicycive Therapeutics3.13 of 5 stars$7.11+12.1%$60.00+743.9%+35.7%$80.14M$680K0.009Trending NewsGap DownTrading HaltedHigh Trading Volume Related Companies and Tools Related Companies Oramed Pharmaceuticals Alternatives Coherus Oncology Alternatives IO Biotech Alternatives Surrozen Alternatives MacroGenics Alternatives Climb Bio Alternatives Cellectis Alternatives TScan Therapeutics Alternatives OKYO Pharma Alternatives Unicycive Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NNVC) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
